Belkin Z P, Egorova T P, Fedosova V G, Balaeva E Ia, Lebenson V I
Zh Mikrobiol Epidemiol Immunobiol. 1989 Aug(8):28-33.
S. flexneri ribosomal preparations were isolated by differential centrifugation or by fractionation with polyethylene glycol-6000. Their chemical composition and spectrophotometric properties were characteristic of ribosomes, and, as shown by the results of the serological assay, the content of O-specific component was, on the average, 1.4%. The ribosomal preparations were nontoxic for mice when injected intraperitoneally and intravenously in large doses and induced systemic O-antibody response in mice and rabbits. The parenteral administration of ribosomes to guinea pigs led to the increase of resistance to Shigella keratoconjunctivitis. The results of different tests with the use of this model greatly varied. According to the summary data of several tests, the ribosomal vaccine enhanced the resistance of the eyes from 11.3% to 48.5% and the effectiveness coefficient of immunization was 42 +/- 6. Ribosomes isolated from S. flexneri avirulent strain 2a 51.6 M (Iu. A. Belaia's vaccine) showed the same activity as those isolated from virulent strains. The results obtained in this study suggest the expediency of further experimental study of ribosomal preparations obtained from S. flexneri as potential vaccine.
通过差速离心或用聚乙二醇-6000分级分离法分离弗氏志贺菌核糖体制剂。它们的化学组成和分光光度特性具有核糖体的特征,并且,血清学检测结果表明,O特异性成分的含量平均为1.4%。当大剂量腹腔内和静脉内注射时,核糖体制剂对小鼠无毒,并在小鼠和兔子中诱导全身O抗体反应。向豚鼠胃肠外给药核糖体导致对志贺菌性角结膜炎的抵抗力增加。使用该模型进行的不同测试结果差异很大。根据几次测试的汇总数据,核糖体疫苗将眼部抵抗力从11.3%提高到48.5%,免疫有效系数为42±6。从弗氏志贺菌无毒菌株2a 51.6 M(柳·阿·别拉娅疫苗)分离的核糖体显示出与从有毒菌株分离的核糖体相同的活性。本研究获得的结果表明,对从弗氏志贺菌获得的核糖体制剂作为潜在疫苗进行进一步实验研究是适宜的。